Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)

NCT00551018 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Vicriviroc
DRUG: emtricitabine and tenofovir disoproxil fumarate

Sponsor

Merck Sharp & Dohme LLC